UBS OCONNOR LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 16 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$24,375,000
+25.5%
25,000,0000.0%0.77%
+29.0%
Q1 2023$19,425,140
-99.9%
25,000,0000.0%0.60%
+43.3%
Q3 2022$21,927,000,000
+3.1%
25,000,0000.0%0.42%
+33.8%
Q2 2022$21,259,000,000
-6.7%
25,000,0000.0%0.31%
+42.0%
Q4 2021$22,780,000,000
+2.8%
25,000,0000.0%0.22%
+25.9%
Q3 2021$22,168,000,000
-3.2%
25,000,0000.0%0.17%
-14.7%
Q2 2021$22,895,000,000
-2.4%
25,000,000
-3.8%
0.20%
-39.6%
Q1 2021$23,448,000,000
+4.7%
26,000,0000.0%0.34%
-26.0%
Q4 2020$22,385,000,000
-1.1%
26,000,000
-6.3%
0.46%
-20.5%
Q3 2020$22,642,000,000
+1.4%
27,750,0000.0%0.58%
+16.6%
Q2 2020$22,339,000,000
+9.5%
27,750,0000.0%0.49%
+17.4%
Q1 2020$20,406,000,000
+2.2%
27,750,0000.0%0.42%
-25.7%
Q4 2019$19,958,000,000
-0.3%
27,750,0000.0%0.56%
+1.4%
Q3 2019$20,019,000,000
+2.5%
27,750,0000.0%0.56%
+47.4%
Q2 2019$19,526,000,00027,750,0000.38%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 20,060,000$23,311,0005.66%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 44,492,000$39,153,0001.56%
UBS OCONNOR LLC 26,000,000$23,448,000,0000.34%
Saltoro Capital, LP 750,000$678,0000.17%
AQR Arbitrage LLC 3,050,000$2,758,0000.10%
WATER ISLAND CAPITAL LLC 1,500,000$1,371,0000.08%
PALISADE CAPITAL MANAGEMENT, LP 3,448,000$3,103,0000.07%
OAKTREE CAPITAL MANAGEMENT LP 5,780,000$5,227,0000.07%
Teton Advisors, Inc. 400,000$358,0000.05%
MACQUARIE GROUP LTD 8,175,000$7,393,0000.01%
View complete list of PARATEK PHARMACEUTICALS INC shareholders